These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10402419)

  • 1. Does i.v. albumin prevent ovarian hyperstimulation syndrome?
    Koike T; Araki S; Ogawa S; Minakami H; Sato I
    Hum Reprod; 1999 Jul; 14(7):1920. PubMed ID: 10402419
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous albumin administration for the prevention of severe ovarian hyperstimulation syndrome: a systematic review and metaanalysis.
    Venetis CA; Kolibianakis EM; Toulis KA; Goulis DG; Papadimas I; Tarlatzis BC
    Fertil Steril; 2011 Jan; 95(1):188-96, 196.e1-3. PubMed ID: 20579987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of intravenous albumin in the prevention of severe ovarian hyperstimulation syndrome.
    Orvieto R; Ben-Rafael Z
    Hum Reprod; 1998 Dec; 13(12):3306-9. PubMed ID: 9886504
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-dose aspirin for prophylaxis of ovarian hyperstimulation syndrome.
    Várnagy A; Koppan M; Manfai Z; Busznyak C; Bodis J
    Fertil Steril; 2008 Apr; 89(4):1035-6. PubMed ID: 18353319
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline.
    ;
    Fertil Steril; 2016 Dec; 106(7):1634-1647. PubMed ID: 27678032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome.
    Asch RH; Ivery G; Goldsman M; Frederick JL; Stone SC; Balmaceda JP
    Hum Reprod; 1993 Jul; 8(7):1015-20. PubMed ID: 8408480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does intravenous albumin prevent ovarian hyperstimulation syndrome?
    Morris RS; Paulson RJ
    Hum Reprod; 1994 Apr; 9(4):753-4. PubMed ID: 8046036
    [No Abstract]   [Full Text] [Related]  

  • 8. Ovarian hyperstimulation: past, present, and future.
    Feinberg EC
    Fertil Steril; 2016 Nov; 106(6):1330. PubMed ID: 27678039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Controlled ovarian hyperstimulation in an in vitro fertilization program. Results and prevention of complications].
    Grochowski D
    Ginekol Pol; 2000 Oct; 71(10):1293-6. PubMed ID: 11143940
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intensive care and treatment of severe ovarian hyperstimulation syndrome].
    Ma MY; Wen WB; Zhou LX; Yu TO; Fang B
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1212-4. PubMed ID: 15485803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can we eliminate severe ovarian hyperstimulation syndrome?
    Orvieto R
    Hum Reprod; 2005 Feb; 20(2):320-2. PubMed ID: 15567876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and management of ovarian hyperstimulation syndrome.
    Chen CD; Chen SU; Yang YS
    Best Pract Res Clin Obstet Gynaecol; 2012 Dec; 26(6):817-27. PubMed ID: 22647872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders.
    Bar-Hava I; Mizrachi Y; Karfunkel-Doron D; Omer Y; Sheena L; Carmon N; Ben-David G
    Fertil Steril; 2016 Aug; 106(2):330-3. PubMed ID: 27114332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous albumin and the prevention of severe ovarian hyperstimulation syndrome.
    Ben-Rafael Z; Orvieto R; Dekel A; Peleg D; Gruzman C
    Hum Reprod; 1995 Oct; 10(10):2750-2. PubMed ID: 8567807
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous albumin and severe ovarian hyperstimulation.
    Shahata M; Yang D; al-Natsha SD; al-Shawaf T
    Hum Reprod; 1994 Nov; 9(11):2186. PubMed ID: 7868696
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ovarian hyperstimulation syndrome--a risk of treatment for infertility].
    Bangsbøll S
    Nord Med; 1997 Sep; 112(7):236-9. PubMed ID: 9380489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome in an in-vitro fertilization programme.
    Ng E; Leader A; Claman P; Domingo M; Spence JE
    Hum Reprod; 1995 Apr; 10(4):807-10. PubMed ID: 7650125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of prerenal azotaemia associated with severe ovarian hyperstimulation syndrome.
    Peces R; Escalada P; Sánchez-Fructuoso A; de la Torre M
    Nephrol Dial Transplant; 1994; 9(3):326-8. PubMed ID: 8052444
    [No Abstract]   [Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Thomas S
    Fertil Steril; 2008 Jul; 90(1):231-3. PubMed ID: 17981269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.